Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Cancer Biol Ther
; 16(2): 307-16, 2015.
Article
en En
| MEDLINE
| ID: mdl-25756513
Palabras clave
AT1R, angiotensin II type 1 receptor; AT2R, angiotensin II type 2 receptor; Ad-, adenoviral vector; Ang II, angiotensin II; BSA, bovine serum albumin; DMEM, Dulbecco`s modification of Eagle`s medium; FBS, fetal bovine serum; GFP, green fluorescent protein; HBSS, Hanks' balanced salt solution; HIF-1, hypoxia inducible factor; Ki, association constant; PCR, polymerase chain reaction; PDAC, pancreatic ductal adenocarcinoma; PI3K, phosphatidylinositol-3 kinase; PLZF, promyelocytic leukemia zinc finger protein; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; VEGF, vascular endothelial growth factor; angiotensin II type 2 receptor (AT2R); apoptosis; cGMP, cyclic guanosine monophosphate; pancreatic ductal adenocarcinoma; selective AT2R agonist
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Pancreáticas
/
Transducción de Señal
/
Carcinoma Ductal Pancreático
/
Receptor de Angiotensina Tipo 2
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Cancer Biol Ther
Asunto de la revista:
NEOPLASIAS
/
TERAPEUTICA
Año:
2015
Tipo del documento:
Article
Pais de publicación:
Estados Unidos